CVC Income & Growth CVC Inc& Grwth-CVCG - Issue of Equity

CVC Income & Growth

12/05/2026 14:51

RNS Number : 0256E

CVC Income & Growth Limited

12 May 2026

 

 

 

 

12 May 2026

CVC Income & Growth Limited

 

Issue of Equity

 

CVC Income & Growth Limited (the Company) announces that on 12 May 2026, it resold from treasury 250,000 Sterling shares for cash at a price of £1.1442 per Sterling share, to meet on-going demand for the Company's shares.

 

Following this issue, the Company's issued share capital (excluding treasury shares) will consist of:

· 193,282,934 ordinary Sterling shares of no par value; and
· 83,794,168 ordinary Euro shares of no par value.

 

Each ordinary Sterling share carries the right to 1.17 vote and each ordinary Euro share carries the right to 1 vote.

 

The total number of voting rights of the ordinary Sterling shares of no par value is 226,141,032 and of the ordinary Euro shares of no par value is 83,794,168. The total number of voting rights in the Company will be 309,935,200.

 

The Company will hold the following ordinary shares in treasury:

 

· 178,726,825 ordinary Sterling shares of no par value (non-voting); and
· 58,306,507 ordinary Euro shares of no par value (non-voting).

 

The figure, 309,935,200, may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in or a change to their interest in the company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Enquiries:

BNP Paribas S.A., Jersey Branch
Company Secretary
cvccpeolcosec@bnpparibas.com
Cadarn Capital
Distribution and Investor Relations
Telephone: +44 20 7019 9042
info@cadarncapital.com
Winterflood Securities
Broker
Telephone: +44 0203 100 0000
Neil Morgan - Corporate Finance
Innes Urquhart - Corporate Sales
Darren Willis - Corporate Sales


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
IOEFLFEVEIIFLIR